Conference News
Discover the latest conference news. Stay informed about upcoming conferences, key speakers, agendas, and significant outcomes. Get insights into industry trends and developments discussed at major conferences.
Nov 7, 2025 at 8:10 AM
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharma Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®...
Nov 7, 2025 at 8:00 AM
Guardant Health to Participate in Upcoming Investor Conferences
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies Global Healthcare Conference in London, UK Fireside chat on Wednesday, November 19 at 9:30 a.m. Greenwich Mean Time Piper Sandler 37th Annual Healthcare Conference in New York, NY Fireside chat on Tuesday, December 2 at 8:30 a.m. Eastern Time Interested parties may access live and archived...
Nov 7, 2025 at 8:00 AM
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi® (seladelpar) for people living with primary biliary cholangitis (PBC). Findings support Livdelzi's consistent efficacy and safety outcomes in patients switching from obeticholic acid and positive impact on liver stiffness over 3 years. These findings were presented at The Liver Meeting® hosted by the American Association for the S...
Nov 7, 2025 at 8:00 AM
CrowdStrike’s Fal.Con 2026 Takes Over Mandalay Bay and Launches the Day Zero Threat Summit
AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced that Fal.Con 2026 will take over the Mandalay Bay Resort in Las Vegas from August 31 – September 3, 2026, and launch the inaugural Day Zero Threat Summit to kick off Fal.Con week – marking the next evolution of the cybersecurity industry’s premier event. Fueled by record-breaking demand following the sold out Fal.Con U.S. and Fal.Con Europe events in 2025, where more than 10,000 professionals from over 4,000 organization...
Nov 7, 2025 at 8:00 AM
Establishment Labs to Present at Jefferies London Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled to present in a fireside chat on Wednesday, November 19, 2025 at 8:30 a.m. GMT. A live webcast of the...
Nov 7, 2025 at 7:31 AM
Gossamer Bio to Participate in Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Company will participate in the following investor conferences in November. UBS Global Healthcare Conference Date / Time: November 10th Format: 1x1’s Location:...
Nov 7, 2025 at 7:01 AM
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced two presentations from the completed Phase 2a PORTOLA clinical trial in patients with autoimmune hepatitis (AIH) at The Liver Meeting 2025 held by the American Association for the Study of Liver Disease (AASLD) and taking place November 7-11, in Washington, DC....
Nov 7, 2025 at 7:00 AM
Coeur to Participate in RBC Capital Markets London Precious Metals Conference
CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) Chairman, President and Chief Executive Officer, Mitchell J. Krebs, will participate in the RBC Capital Markets Precious Metals Conference in London, United Kingdom on Tuesday, November 11, 2025. The RBC Capital Markets Precious Metals Conference is an invitation-only investment conference. Presentation materials will be made available on the Company’s website at www.coeur.com. About Coeur Coeur Mining, Inc. i...
Nov 7, 2025 at 7:00 AM
TwoStep Therapeutics to Present at the 2025 SITC Annual Meeting
SAN CARLOS, Calif.--(BUSINESS WIRE)--TwoStep Therapeutics to Present at the 2025 SITC Annual Meeting...
Nov 7, 2025 at 7:00 AM
Mobileye Announces Participation in Upcoming Fourth Quarter 2025 Investor Conferences
JERUSALEM--(BUSINESS WIRE)--Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) announced today that it is scheduled to participate in the following upcoming investor events in the fourth quarter of 2025. Baird’s 2025 Global Industrial Conference, November 11, 2025 Wells Fargo 9th Annual TMT Summit, November 19, 2025 UBS Global Industrials and Transportation Conference 2025, December 3, 2025 Mobileye plans to webcast its “fireside chats” when possible, with exact time to be posted closer to the ev...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.